Peptic Ulcer
Information
- Disease name
- Peptic Ulcer
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT04702542 | Active, not recruiting | N/A | To Develop Methods for the Rehabilitation of Chronic Gastroduodenal Pathology in Children. | January 4, 2020 | December 30, 2028 |
| NCT00153712 | Completed | Natural History of Non-steroidal Anti-inflammatory Drug and Non-Helicobacter Pylori in Bleeding Peptic Ulcers | August 2002 | July 2009 | |
| NCT00152399 | Completed | Phase 2 | Study to Assess the Efficacy and Safety of Somatostatin in the Treatment of Acute Severe Upper Gastrointestinal Bleeding | September 2000 | October 2005 |
| NCT00164866 | Completed | Phase 4 | Administration of High-Dose Intravenous Proton Pump Inhibitor for Upper Gastrointestinal Bleeding Prior to Endoscopy | February 2004 | September 2005 |
| NCT00175032 | Completed | Phase 3 | A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose Aspirin | July 2003 | July 2004 |
| NCT00212225 | Completed | Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori) | October 1997 | December 2007 | |
| NCT00325715 | Completed | Phase 1 | AGN 201904 Versus Esomeprazole in the Prevention of Aspirin-induced Stomach or Upper Intestinal Damage in Healthy Volunteers | April 2006 | August 2006 |
| NCT05237115 | Completed | Phase 4 | Helicobacter Pylori Eradication With Probiotics Combined With Triple Therapy Versus Bismuth-containing Quadruple Therapy | May 5, 2020 | December 5, 2020 |
| NCT00450658 | Completed | Phase 3 | Efficacy and Safety Study of HZT-501 in Reducing the Risk of Ibuprofen-associated Ulcers | March 2007 | October 2008 |
| NCT00534443 | Completed | Phase 4 | Importance of Cytokines in Peptic Ulcer Disease: Implications for Treatment | February 2007 | September 2009 |
| NCT04678492 | Completed | Phase 4 | Helicobacter Rescue Therapy With High-dose Esomeprazole and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy | December 20, 2020 | December 20, 2021 |
| NCT04636866 | Completed | The Prevalence of Helicobacter Pylori in Shanghai, 2013 to 2019 | February 10, 2020 | September 16, 2020 | |
| NCT03367897 | Completed | Bleeding Ulcer and Erosions Study "BLUE Study" | March 2015 | July 2019 | |
| NCT02536989 | Completed | Phase 4 | Different Dose of Intravenous Omeprazole to Treat Bleeding Ulcer With Adherent Clot | March 2009 | July 2012 |
| NCT02551744 | Completed | N/A | Proton Pump Inhibitor Versus Histamine-2 Receptor Antagonist for the Prevention of Recurrent Peptic Ulcers | July 2012 | July 2018 |
| NCT00920400 | Completed | Diagnostic Value of Fecal Calprotectin in Disorders of the Upper Gastrointestinal Tract | March 2008 | December 2009 | |
| NCT00977678 | Completed | Drop in Gastroscopy - Experience After 9 Months | November 2009 | December 2009 | |
| NCT01080326 | Completed | N/A | Feasibility of Translumenal Endoscopic Omental Patch Closure of Perforated Viscus | March 2010 | December 2012 |
| NCT01138969 | Completed | Phase 2 | Efficacy of Proton Pump Inhibitor in Prevention of Clopidogrel-related Peptic Ulcer | August 2008 | December 2012 |
| NCT01142180 | Completed | N/A | Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis | January 2010 | July 2014 |
| NCT01142245 | Completed | Phase 3 | Effect of IV and Oral Esomeprazole in Prevention of Recurrent Bleeding From Peptic Ulcers After Endoscopic Therapy | January 2008 | July 2014 |
| NCT01180179 | Completed | Phase 4 | PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding Ulcers | June 2010 | May 2019 |
| NCT01282853 | Completed | N/A | Rapid Urease Test for Diagnosis of H. Pylori Infection in Patients With Peptic Ulcer Bleeding | August 2010 | June 2011 |
| NCT01353144 | Completed | Phase 4 | A Comparison of Two Therapeutic Strategies for the Treatment of Aspirin-associated Peptic Ulcers | June 2007 | May 2008 |
| NCT01376414 | Completed | H. Pylori Testing for Patients With Non-specific Upper Abdominal Pain in the Emergency Department | March 2011 | March 2015 | |
| NCT01453036 | Completed | Phase 4 | Clarithromycin Resistant Tailored Therapy | August 2011 | June 2012 |
| NCT01667575 | Completed | Phase 4 | Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori | August 2012 | May 2013 |
| NCT01667692 | Completed | Phase 4 | Aizthromycin or Clarithromycin in H-pylori Eradication Regimen | March 2011 | March 2012 |
| NCT01667718 | Completed | Phase 4 | Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment | May 2012 | October 2012 |
| NCT01828645 | Completed | Phase 2/Phase 3 | Residual Gastric Volume After the Ingestion of a Beverage Containing Carbohydrates Plus Whey Protein | February 2013 | March 2013 |
| NCT01838109 | Completed | N/A | Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery | April 2013 | April 2014 |
| NCT02648659 | Completed | Phase 4 | The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients | March 2, 2016 | February 14, 2017 |
| NCT02633930 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy | December 2015 | August 2016 |
| NCT02084420 | Completed | Phase 3 | Efficacy/Safety Study as H. Pylori Eradication of Triple Therapy for 7 Days Treatment | December 2012 | January 2014 |
| NCT02175901 | Completed | Phase 4 | Amoxicillin/Metronidazole Based Quadruple Therapy for Helicobacter Pylori Eradication | July 2014 | January 2015 |
| NCT02296021 | Completed | Phase 4 | Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Bismuth-containing Quadruple Therapy | November 2014 | September 2015 |
| NCT02342470 | Completed | Phase 2 | Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users | November 24, 2014 | December 8, 2017 |
| NCT02418312 | Completed | N/A | Efficacy of H2 Receptor Antagonist in Prevention of Thienopyridine-related Peptic Ulcer | January 2012 | October 2017 |
| NCT02581696 | Completed | Phase 1 | The Drug-drug Interaction and Safety of Lafutidine and Irsogladine Maleate in Healthy Adult Volunteers | August 2015 | November 2015 |
| NCT03228095 | Enrolling by invitation | Volatiles in Breath and Headspace Analysis - Diagnostic Markers | July 24, 2017 | December 31, 2025 | |
| NCT06439563 | Not yet recruiting | Phase 3 | Study to Evaluate the Efficacy and Safety of JP-1366 in the Prevention of NSAIDs-Induced Peptic Ulcers | August 2024 | December 2027 |
| NCT06284876 | Not yet recruiting | Phase 3 | Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer | August 30, 2024 | February 28, 2027 |
| NCT05742568 | Recruiting | Phase 4 | Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology | December 1, 2022 | March 10, 2024 |
| NCT04025983 | Terminated | N/A | Effectiveness of GastimunHp Plus in Supporting the Treatment of Peptic Ulcer Disease With Helicobacter Pylori Infection | November 1, 2019 | October 1, 2021 |
| NCT04140591 | Terminated | Phase 2/Phase 3 | Proton Pump Inhibitor Plus Propranolol Versus Proton Pump Inhibitor Alone on Peptic Ulcer Healing in Patients With Liver Cirrhosis | December 26, 2016 | December 31, 2019 |
| NCT00766961 | Terminated | N/A | TAE and Surgery in Patients With Peptic Ulcer Bleeding Uncontrolled by Endoscopic Therapy | April 2007 | December 2017 |
| NCT03814421 | Unknown status | N/A | Efficacy of Low Dose Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding | April 15, 2016 | October 31, 2021 |
| NCT03868267 | Unknown status | Japanese Upper GI Symptoms Compared With Iranian and Canadian Patients Presenting | May 9, 2019 | December 1, 2023 | |
| NCT00709046 | Unknown status | N/A | High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic Treatment | January 2008 | |
| NCT00471029 | Unknown status | Phase 4 | Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer | September 2005 | September 2007 |
| NCT04784910 | Unknown status | Phase 3 | Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer | March 2021 | February 28, 2022 |
| NCT00441831 | Unknown status | The Revolutions of Helicobacter Pylori Infection, Bacterial Density, and Histological Features After Antrectomy | February 2007 | February 2008 | |
| NCT02436018 | Unknown status | N/A | WEI NASAL JET for The Sedation of Outpatient Upper Gastrointestinal Endoscopy | March 2015 | November 2016 |
| NCT01979549 | Unknown status | Adverse Events During Upper Gastrointestinal Endoscopy | December 2013 | December 2014 | |
| NCT02961296 | Unknown status | Helicobacter Pylori Antibiotic Susceptibility Testing of Korea | October 2016 | December 2018 | |
| NCT00854776 | Unknown status | N/A | Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump Inhibitor | January 2009 | December 2010 |
| NCT02001727 | Unknown status | N/A | HEP-FYN 12-Years Follow-up | March 2012 | February 2015 |
| NCT00161096 | Unknown status | Phase 3 | On-Demand Use of Pantoprazole: Determinants for Chronic Use of Acid Suppressive Medication | March 2004 | September 2005 |
| NCT00881413 | Withdrawn | Phase 4 | Esomeprazole Versus Pantoprazole to Prevent Peptic Ulcer Rebleeding |
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0004398
- MeSH unique ID (MeSH (Medical Subject Headings))
- D010437